Los Angeles Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $5.04K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $596K | Sell |
|
|||||
|
2024
Q2 | $694K | Sell |
|
|||||
|
2024
Q1 | $1.5M | Sell |
|
|||||
|
2023
Q4 | $1.3M | Buy |
|
|||||
|
2023
Q3 | $989K | Buy |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | $922K | Sell |
|
|||||
|
2022
Q4 | $1.17M | Buy |
|
|||||
|
2022
Q3 | $882K | Buy |
|
|||||
|
2022
Q2 | $168K | Buy |
|
|||||
|
2022
Q1 | $182K | Hold |
|
|||||
|
2021
Q4 | $376K | Buy |
|